LITSNasdaqPharmaceutical PreparationsFiscal year ends June 30
Lite Strategy, Inc.
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026
$1.16+0.01 (+0.87%)
Close on Oct 19, 2026
- Market cap
- $40.13M
- P/E (TTM)
- –
- Dividend yield
- –
Lite Strategy, Inc. balance sheet
Ratios
Latest available, balances at Jun 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2026
- -243.0%
Financial strength
- Current ratio
- 5.74
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 533.8%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.96
- Dividend yield
- –